JCMClass II
Control, Hemoglobin, Abnormal
21 CFR 864.7415 / Hematology
JCM is the FDA product code for Control, Hemoglobin, Abnormal, a class II device type, regulated under 21 CFR 864.7415. As of , FDA records hold 12 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- JCM
- Device name
- Control, Hemoglobin, Abnormal
- Regulation
- 21 CFR 864.7415
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 12
- Ingested recalls
- 1
Clearances, product code JCM
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1982 | 2 |
| 1991 | 3 |
| 1992 | 1 |
| 1993 | 1 |
| 1994 | 1 |
| 1995 | 1 |
| 1999 | 1 |
| 2001 | 1 |
| 2005 | 1 |
Applicants with the most clearances
Product code JCM| Applicant | Clearances |
|---|---|
| Isolab, Inc. | 4 |
| Helena Laboratories, Corp. | 2 |
| Bio-Rad | 1 |
| Cantebury Scientific, Ltd. | 1 |
| Canterbury Health Laboratories | 1 |
| Creative Laboratory Products, Inc. | 1 |
| Diagnostic Technology, Inc. | 1 |
| Roche Diagnostic Systems, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
